@akMD03

GI-IBD & Assoc. Program Director @AHNGastro || Assistant Prof. of Medicine @DrexelMedicine || Alumni @MayoClinicFLGIH @metrohealthCLE @cwrusom

 Pittsburgh, PA
Joined June 2019
  • Tweets122
  • Following639
  • Followers299
6Media
Five Things to Know About Weight-Loss Drugs and IBD - some thoughts on this #SalishHonap, @akMD03 and myself medpagetoday.com/spotlight/d…

Five Things to Know About Weight-Loss Drugs and IBD

Early data are promising, but GLP-1 drugs aren't yet recommended as IBD therapy

medpagetoday.com
4
3
409
Check out our narrative review on GLP-1RA use in IBD in @AGA_GHAdvances Existing data is exciting but not without limitations. Promising RCTs underway. Appreciate the opportunity and mentorship from @FarrayeIBD @hanyhabib97 @LinaWahbeh00 @AHNGastro sciencedirect.com/science/ar…
1
3
5
310
Our 📄 on recent trends in advanced therapy utilization for IBD in the US published in @JCC_IBD @GKochharMD #siddharthsinghmd academic.oup.com/ecco-jcc/ad…

Trends in utilization of advanced therapies in patients with inflammatory bowel diseases in the...

AbstractBackground and Aims. Seven new advanced therapies, belonging to three new classes, have been approved for the treatment of inflammatory bowel disea

academic.oup.com
1
1
7
736
☀️ Idea → 🎬 ACG2024 → 📝publication! What links EoE and IBD? ❓Do IBD patients carry a higher risk of developing EoE? ❓Risk modifiers? ❓Natural history when EoE+IBD vs EoE-only? @akMD03 @GKochharMD @FarrayeIBD @JHashashMD 🔗 share.google/AIU7m5eo3cWLQo0… – at Reserve Township, PA
2
4
1
25
8,892
GLP-1RA use and clinical outcomes in IBD: Systematic Review and Meta Analysis published in @JCC_IBD. Great collaboration with international colleagues. academic.oup.com/ecco-jcc/ad…
2
1
2
580
🚀Dive into the future of IBD care at the 7th Annual AHN IBD Summit happening Saturday, October 4, 2025! 🚀 Explore innovations in endoscopic management, updates on biosimilars, & IBD in pregnancy. Register now at cme.ahn.org! #IBDsummit #AHN #gastroenterology
1
7
3
22
4,037
Efficacy of tirzepatide for weight loss and it’s comparative effectiveness to weight loss surgery in inflammatory bowel disease @FarrayeIBD @GKochharMD #GITwitter #IBD link.springer.com/article/10…
1
4
2
8
2,075
Welcome to our new 1st year fellows! Excited to be a part of your fellowship journey. Looking forward to working with all our fellows this year!
AHN Gastroenterology, Hepatology and Nutrition@AHNGastro1 Jul 2025
Gut feeling says these 1st year GI fellows are going to be AMAZING! 🎉 Big welcome to Dr. Jacubowsky, Dr. Gries, Dr. Cohen & Dr. Amin! Plus, HUGE congrats to @AkashGadaniMD, our new Program Director, & @akMD03, our new Associate Program Director! #GIFellows #GI #AHNToday
11
352
We are honored to receive this award from @IBDJournals and @CrohnsColitisFn! Incredibly fortunate to have @GKochharMD as a mentor. Thank you to all the co-authors for their support and expertise @FarrayeIBD @JHashashMD @MRegueiroMD
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
1
3
13
1,313
Great collaboration between @MilestoneIBD alumni @phillyIBDdoc Thank you to @APandT for publishing our work! @GKochharMD @FarrayeIBD @Himsikhar1 @AHNGastro
roypounder.apt@APandT28 Jan 2025
Patients with obesity and ulcerative colitis are at an increased risk of composite outcome of steroid use, change in advanced therapy and colectomy. Read the paper by Desai et al at bit.ly/3EgU9mP #obesity #ulcerativecolitis #IBD #GItwitter
The UC obesity cohort was at an increased risk of the composite outcome of corticosteroid use, change in therapy and colectomy compared to the UC control cohort in patients on advanced therapies including TNFi, vedolizumab, ustekinumab and JAKi.

ALT The UC obesity cohort was at an increased risk of the composite outcome of corticosteroid use, change in therapy and colectomy compared to the UC control cohort in patients on advanced therapies including TNFi, vedolizumab, ustekinumab and JAKi.

2
14
1,045
Excited to share: Obesity assoc w worse outcomes in UC @APandT @akMD03 @JamesLewisGIEpi @PennIBDDoc @GKochharMD @FarrayeIBD ✔️UC pts w/ BMI > 30 had inc risk of steroid use, change in therapy, and colectomy ✔️Seen in pts on vedo, UST, anti-TNF & JAKi pubmed.ncbi.nlm.nih.gov/3984…

Obesity Is Associated With Worsened Outcomes in Patients With Ulcerative Colitis on Advanced...

Obesity is associated with lower efficacy of several advanced therapies in patients with UC.

pubmed.ncbi.nlm.nih.gov
1
8
1
30
2,341
From presenting 3️⃣ posters at Western PA ACP @ACPIMPhysicians to 1️⃣1️⃣ at @AmCollegeGastro over two back to back days, with heartfelt recognitions 🏆🎖 for our team's dedication! @AHNIMres @AHNGastro @AHNMedicineInst
9
10
1
50
4,705
💊Have you ever had a patient with #IBD who previously failed TOFA and wondered if there is opportunity to use UPA for treatment? Check out our paper from the #IBD group at @MayoClinicFLGIH @FarrayeIBD @JHashashMD @ibdgijami @ChristianKarime 📖 rdcu.be/dTubC
2
15
1
53
4,293
What are the various endoscopic techniques to manage dysplasia in IBD❔ We summarized it for you!! 🙏🙏 @GKochharMD @akMD03 🔑 Role of AI in detection 🔑 ESD in IBD 🔑 Full thickness resection & More!! ↘️↘️↘️ 📜 link.springer.com/article/10…
1
5
1
24
1,461
New study: Patients with IBD at higher risk for RSV hospitalization (aOR 1.30) Key findings: ↑ risk in 18-49 & 65+ age groups IBD + CVD: 3.35x hospitalization risk Recent steroids ↑ risk (aOR 1.86) journals.lww.com/ajg/abstrac…

Patients With Inflammatory Bowel Disease Are at... : American Journal of Gastroenterology

INTRODUCTION:Patients with inflammatory bowel disease (IBD) are at increased risk of developing respiratory infections. Respiratory syncytial virus...

journals.lww.com
4
12
2
33
6,617
Load more